Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 58. Отображено 58.
18-07-2018 дата публикации

SOLUBILIZING AGENT FOR TRANSPARENT OR TRANSLUCENT OIL-IN-WATER FORMULATION, AND COSMETIC COMPOSITION INCLUDING SAME

Номер: KR1020180081948A
Принадлежит:

The present specification relates to a solubilizing agent for a transparent or translucent oil-in-water formulation, which is used for a transparent or translucent oil-in-water formulation including a fat-soluble bioactive material, and comprises a polysorbate 20-cinnamic acid conjugate in which polysorbate 20 and cinnamic acid are bound to each other, and to a cosmetic composition including the same. The solubilizing agent and the composition including the same have excellent water dispersion stability with respect to a water phase of the fat-soluble bioactive material. COPYRIGHT KIPO 2018 (AA) Form that 1,2, or 3 cinnamic acid is bound to an OH group ...

Подробнее
19-04-2023 дата публикации

알팔파 씨앗에서 추출된 다당체를 유효성분으로 함유하는 화장료 조성물

Номер: KR102523606B1

... 본 발명은 알팔파 씨앗에서 추출된 다당체 함유 추출물을 유효성분으로 함유하는 화장료 조성물 및 피부 외용제 조성물에 관한 것으로서, 상기 다당체를 함유함으로써 엘라스타제의 생성을 억제하여 주름을 개선하고 멜라닌 생성을 억제하여 피부 미백 효과가 뛰어날 뿐만 아니라, 각질 형성 세포 분화를 촉진하여 피부장벽을 강화하고 항염증 효과가 우수한 화장료 조성물 및 피부 외용제를 제공할 수 있다.

Подробнее
02-12-2010 дата публикации

COMPOSITION CONTAINING A BEAN EXTRACT FOR IMPROVING BLOOD CIRCULATION AND INCREASING VASCULAR HEALTH

Номер: KR2010137875A2
Принадлежит:

The present invention relates to a composition containing a bean extract extracted by low-concentration, low-grade alcohol or fractions thereof. The composition exhibits excellent effects in improving blood circulation, improving obesity, and preventing diabetes, hyperlipidemia and the like, and exhibits the effects of alleviating or treating the symptoms of diabetes, hyperlipidemia, and the like.

Подробнее
05-04-2018 дата публикации

COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND SOLUBILIZING AGENT

Номер: WO2018062958A1
Принадлежит:

The present specification relates to a skin external composition comprising: a solute which is a benzoic acid amide compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof; and at least one first solubilizing agent selected from among diethylene glycol monoethyl ether, methyl gluceth, glycerol ether, polyethylene glycol, and a polyethylene glycol/propylene glycol copolymer, and provides a skin external composition with improved solubility and feeling of use.

Подробнее
03-11-2015 дата публикации

COMPOSITION CONTAINING COLORED BEAN EXTRACT

Номер: KR1020150123205A
Принадлежит:

The present invention relates to an antithrombotic composition which contains, as an active ingredient, colored-bean extracts obtained from colored beans or the like and a fraction thereof. The antithrombotic composition according to the present invention contains adenosines and can be significantly and effectively used in treatment of circulatory diseases which can cause thrombopoiesis and includes cardiovascular diseases, cerebrovascular diseases, atherosclerosis, hypertension, diabetes, and the like. COPYRIGHT KIPO 2016 (AA) Platelet coagulation inhibiting rate(%) (BB) Time(Minute) ...

Подробнее
23-12-2010 дата публикации

COSMETIC COMPOSITION COMPRISING CHESTNUT SHELL EXTRACT

Номер: KR2010147441A2
Принадлежит:

The present invention relates to a cosmetic composition for alleviating or suppressing pruritus, comprising chestnut shell extract as an active ingredient. According to one embodiment of the present invention, the cosmetic composition containing the chestnut shell extract is suitable for use as an active ingredient in a cosmetic composition for alleviating or suppressing pruritus since it has exhibited proven, superior effects in alleviating or suppressing pruritus by suppressing the activity of proteinase-activated receptor-2 (PAR-2) which is a causative agent for pruritus.

Подробнее
23-12-2010 дата публикации

COSMETIC COMPOSITION COMPRISING CHESTNUT SHELL EXTRACT

Номер: WO2010147441A3
Принадлежит:

The present invention relates to a cosmetic composition for alleviating or suppressing pruritus, comprising chestnut shell extract as an active ingredient. According to one embodiment of the present invention, the cosmetic composition containing the chestnut shell extract is suitable for use as an active ingredient in a cosmetic composition for alleviating or suppressing pruritus since it has exhibited proven, superior effects in alleviating or suppressing pruritus by suppressing the activity of proteinase-activated receptor-2 (PAR-2) which is a causative agent for pruritus.

Подробнее
22-12-2011 дата публикации

COMPOSITION CONTAINING COLORED BEAN EXTRACT

Номер: WO2011159133A3
Принадлежит:

The present invention relates to an antithrombogenic composition containing a colored bean extract extracted from colored beans and the like and a fraction thereof as active ingredients. The antithrombogenic composition according to the present invention can be very useful to treating diseases of the circulatory system such as cardiovascular diseases, cerebral vascular diseases, arteriosclerosis, hypertension, diabetes and the like caused by thrombus formation.

Подробнее
03-03-2016 дата публикации

NOVEL ADAMANTANE DERIVATIVE COMPOUND

Номер: WO2016032182A1
Принадлежит:

Disclosed is a novel adamantane derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate thereof, or a solvate thereof. In addition, disclosed is a method for preparing the novel adamantane derivative compound, the isomer thereof, the pharmaceutically acceptable salt thereof, the prodrug thereof, the hydrate thereof, or the solvate thereof. The novel adamantane derivative compound or the like has an excellent androgen inhibitory effect.

Подробнее
10-10-2016 дата публикации

NOVEL BENZOIC ACID AMIDE COMPOUND

Номер: KR1020160116861A
Принадлежит:

Disclosed is a novel benzoic acid amide derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a pro-drug thereof, a hydrate thereof, or a solvate thereof. The novel compound of the present invention suppresses melanin production and inhibits activities of tyrosinase, while showing outstanding skin whitening effects. COPYRIGHT KIPO 2016 ...

Подробнее
07-09-2016 дата публикации

METHOD TO PREDICT SIDE EFFECTS OF WHITENING COMPONENTS

Номер: KR1020160105646A
Принадлежит:

An aspect of the present invention relates to a method to predict side effects of whitening components. The method comprises a step of measuring at least one among: i) the amount of increase in toxicity with respect to a long term use of the whitening components; ii) a difference between the concentration of the whitening components exhibiting efficacy in whitening and the concentration exhibiting cell toxicity; and iii) the amount of increase in sensitivity of the whitening components with respect to UV treatment as a pretreatment. The method effectively predicts whether side effects occur or not when the whitening components are used for a long period of time. COPYRIGHT KIPO 2016 ...

Подробнее
06-10-2016 дата публикации

ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE

Номер: WO2016159640A2
Принадлежит:

... 5-Adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide disclosed in the present specification can exhibit excellent anti-oxidative and anti-aging effects while having no toxicity. For example, the compound exhibits excellent anti-oxidative and anti-aging effects by scavenging free radicals or inhibiting MMP-1 expression.

Подробнее
05-06-2014 дата публикации

NOVEL PSEUDOCERAMIDE COMPOUND AND PRODUCTION METHOD FOR SAME

Номер: WO2014084676A1
Принадлежит:

The present invention provides: a novel pseudoceramide compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate thereof or a solvate thereof. The present invention has a skin protecting effect in that the invention has a superior effect in skin moisturisation and is outstandingly stable and soluble, and thus the invention can protect the skin from external irritation without side effects, and can be used as an active substance in damaged skin recovery and prevention. Consequently, the invention can be used as a skin-moisturising dermatological external composition, cosmetic composition or pharmaceutical composition.

Подробнее
09-12-2016 дата публикации

신규한 자외선 흡수제용 퀴녹살린계 화합물

Номер: KR0101684671B1
Принадлежит: (주)아모레퍼시픽

... 본 발명은 신규한 퀴녹살린계 화합물, 그의 이성질체, 그의 전구약물, 또는 그의 약학적으로 허용 가능한 염, 수화물 또는 용매화물을 제공한다. 상기 퀴녹살린계 화합물은 UVA 및 UVC 영역의 자외선을 흡수할 수 있어서, 자외선 흡수제나, 노화방지용 약학조성물 또는 노화방지용 화장료 조성물로 유용하게 사용할 수 있다.

Подробнее
07-09-2022 дата публикации

벤조산아마이드 화합물 및 용해보조제를 포함하는 조성물

Номер: KR102441382B1
Принадлежит: (주)아모레퍼시픽

... 본 명세서에는 벤조산 아마이드 화합물, 이의 이성질체, 이의 약학적으로 허용 가능한 염, 이의 수화물 또는 이의 용매화물인 용질; 및 디에틸렌글라이콜모노에틸에테르, 메틸글루세스, 글라이세릴에테르, 폴리에틸렌글라이콜 및 폴리에틸렌글라이콜/폴리프로필렌글라이콜 코폴리머 중 어느 하나 이상인 제 1 용해보조제;를 포함하는 피부 외용제 조성물에 관한 것으로, 용해도 및 사용감이 개선된 피부 외용제 조성물을 제공한다.

Подробнее
16-07-2018 дата публикации

콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물

Номер: KR0101876471B1
Принадлежит: (주)아모레퍼시픽

... 본 발명은 저농도 저급 알코올로 추출한 콩 추출물 또는 그 분획물을 함유하는 조성물에 관한 것이다. 상기 조성물은 혈액 순환 개선 효과가 우수하고, 비만 상태를 개선시키며, 당뇨 및 고질혈증 등의 예방, 증상의 완화 또는 치료에 효과적이다.

Подробнее
11-01-2017 дата публикации

COMPOSITION CONTAINING COLORED BEAN EXTRACT

Номер: KR1020170004937A
Принадлежит:

The present invention relates to an antithrombotic composition containing a colored bean extract extracted from colored beans and a fraction thereof as active ingredients. According to the present invention, the antithrombotic composition contains adenosine, and can be useful for treating circulatory diseases such as cardiovascular disease, cerebrovascular disease, arteriosclerosis, high blood pressure, and diabetes, causing thrombogenesis. COPYRIGHT KIPO 2017 (AA) Suppressing rate of platelet aggregation (%) (BB) Time (minutes) ...

Подробнее
01-09-2016 дата публикации

METHOD FOR PREDICTING SIDE EFFECT OF WHITENING INGREDIENT

Номер: WO2016137270A1
Принадлежит:

In one aspect of the present specification, provided is a method for predicting a side effect of a whitening ingredient, the method comprising measuring at least one of i) the increase in toxicity according to long-term use of a whitening ingredient, ii) the difference between a concentration having whitening effect and a concentration having cell toxicity, and iii) the increase in sensitivity to the whitening ingredient according to ultraviolet pretreatment. In addition, the method has an effect of effectively predicting whether a side effect will occur if the whitening ingredient is used for a long time.

Подробнее
08-03-2012 дата публикации

NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR

Номер: WO2012030170A3
Принадлежит:

Disclosed are a novel compound acting as a cannabinoid receptor-1 inhibitor, a prodrug thereof, a pharmaceutically acceptable salt thereof, and a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by cannabinoid receptor-1.

Подробнее
27-06-2016 дата публикации

COMPOSITION CONTAINING COLORED BEAN EXTRACT

Номер: KR1020160073950A
Принадлежит:

The present invention relates to an antithrombotic composition which contains, as active ingredients, a colored bean extract extracted from colored beans and a fraction thereof. The antithrombotic composition of the present invention contains adenosine and can be useful for treating circulatory diseases such as cardiovascular diseases, cerebrovascular diseases, atherosclerosis, hypertension, and diabetes which are causative of the thrombus formation. COPYRIGHT KIPO 2016 (AA) Platelet coagulation inhibition rate(%) (BB) Time(minutes) ...

Подробнее
05-04-2018 дата публикации

PSEUDO-CERAMIDE COMPOUND AND PREPARATION METHOD THEREFOR

Номер: WO2018062729A1
Принадлежит:

The present invention relates to a pseudo-ceramide compound and a preparation method therefor. According to the present invention, the pseudo-ceramide compound has a molecular structure and a function similar to those of a natural ceramide, can be readily synthesized, and has excellent solubility in an organic solvent and excellent stability, and thus the pseudo-ceramide compound can be used as an alternative to a natural ceramide. Therefore, the pseudo-ceramide compound of the present invention can be widely applied to a skin preparation for external use, a cosmetic composition, and the like for reinforcing and maintaining a skin barrier function.

Подробнее
16-03-2016 дата публикации

Novel benzoic acid amide compound

Номер: KR0101604053B1
Принадлежит: (주)아모레퍼시픽

... 본 발명은 신규 벤조산아미드 유도체 화합물, 이의 이성질체, 이의 약학적으로 허용 가능한 염, 이의 프로드럭, 이의 수화물 또는 이의 용매화물을 개시한다. 상기 신규 화합물 등은 뛰어난 피부 미백 효과를 가진다.

Подробнее
06-10-2016 дата публикации

NOVEL BENZOIC ACID AMIDE COMPOUND

Номер: WO2016159644A1
Принадлежит:

Disclosed are a novel benzoic acid amide derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate thereof or a solvate thereof. The novel compound and the like inhibit melamine generation, inhibit tyrosinase activity and have an excellent skin whitening effect.

Подробнее
29-04-2016 дата публикации

COMPOSITION FOR EXTERNAL APPLICATION, CONTAINING MESO-2,3-BUTANEDIOL AS PRESERVATIVE

Номер: KR1020160046639A
Принадлежит:

The present invention relates to a composition for external application, which contains meso-2,3-butanediol which is an isomer of 2,3-butanediol, represented by chemical formula 1, so as to have an excellent preservative activity even without chemical preservatives, and to have excellent feeling on the skin by being less irritating. COPYRIGHT KIPO 2016 ...

Подробнее
30-10-2015 дата публикации

COMPOSITION CONTAINING COLORED-BEAN EXTRACTS

Номер: KR1020150122102A
Принадлежит:

The present invention relates to an antithrombotic composition which contains, as active ingredients, fractions of colored-bean extracts obtained from colored beans or the like. According to the present invention,the antithrombotic composition contains adenosine and can be effectively used in the treatment of circulatory diseases such as cardiovascular diseases, cerebrovascular diseases, atherosclerosis, hypertension, diabetes, and the like, which cause formation of thrombi. COPYRIGHT KIPO 2016 (AA) Platelet aggregation inhibition(%) (BB) Collagen (CC) Time(Minute) ...

Подробнее
02-11-2018 дата публикации

카나비노이드 1 수용체 저해제로 작용하는 신규 화합물

Номер: KR0101914161B1
Принадлежит: (주)아모레퍼시픽

... 본 발명은 카나비노이드 1 수용체 저해제로 작용하는 신규 화합물, 이의 프로드럭, 이의 약학적으로 허용 가능한 염, 이의 수화물 또는 이의 용매화물을 개시한다. 상기 신규 화합물 등은 카나비노이드 1 수용체 매개 질환의 예방 또는 치료용으로 유용하다.

Подробнее
20-05-2010 дата публикации

NOVEL COMPOUND ACTING AS A VANILLOID RECEPTOR ANTAGONIST, ISOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Номер: WO2010056044A3
Принадлежит:

The present invention relates to a novel compound acting as a vanilloid receptor (VR1; TRPV1) antagonist, to an isomer or pharmaceutically acceptable salt thereof, and to a pharmaceutical composition containing same. The present invention provides a pharmaceutical composition for preventing or treating diseases such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, respiratory disorder, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease, etc. The present invention also provides a composition for preventing skin aging, or to a composition for alleviating skin irritation.

Подробнее
23-12-2010 дата публикации

HEALTH FOOD OR PHARMACEUTICAL COMPOSITION COMPRISING CHESTNUT SHELL EXTRACT

Номер: KR2010147440A2
Принадлежит:

The present invention relates to a health food or pharmaceutical composition for alleviating or suppressing pruritus, comprising chestnut shell extract as an active ingredient. In one example of the present invention, the chestnut shell extract comprised in the health food or pharmaceutical composition of the present invention can suitably be used as the active ingredient of a health food or pharmaceutical composition for alleviating or suppressing pruritus as it has been confirmed that it can exhibit an outstanding effect in alleviating or suppressing pruritus by suppressing the activity of proteinase-activated receptor-2 (PAR-2) which is a source of stimulation in pruritus.

Подробнее
09-01-2017 дата публикации

PREPARATION METHOD OF BENZOIC ACID AMIDE COMPOUNDS

Номер: KR1020170003387A
Принадлежит:

The present invention relates to a manufacturing method of benzoic acid amide compounds with high yield by providing a novel manufacturing method of benzylamine compounds used as reactants and limiting reaction conditions of each step by using the same. According to the present invention, mass-production is possible so the method is economically advantageous. The method comprises the step of performing amide coupling reaction of a benzyl amine compound and an adamantanyl benzoic anhydride. COPYRIGHT KIPO 2017 ...

Подробнее
22-12-2011 дата публикации

COMPOSITION CONTAINING COLORED-BEAN EXTRACTS

Номер: KR2011159134A2
Принадлежит:

The present invention relates to an antithrombotic composition which contains, as active ingredients, fractions of colored-bean extracts obtained from colored beans or the like. The antithrombotic composition of the present invention can be significantly effectively used in the treatment of cardiovascular diseases, cerebrovascular diseases, and circulatory diseases such as atherosclerosis, hypertension, diabetes, and the like, wherein the diseases are caused by the formation of thrombi.

Подробнее
22-01-2024 дата публикации

베타 아미노산 유도체를 포함하는 유중수 유화 조성물

Номер: KR20240009111A
Принадлежит:

... 본원에는 아미노산 유도체를 유효성분으로 포함하는 오일 점증제 및 아미노산 유도체를 포함하는 유중수 유화 조성물이 개시된다. 상기 유중수 유화 조성물은 외상에 오일 점증제로서 아미노산 유도체를 포함하여 종래 오일 점증제의 오일 점증 효과가 낮고 무거운 사용감을 유발하는 단점을 개선하는 효과가 있다. 또한, 종래 유중수 유화 조성물의 가장 큰 문제점인 제형 안정도가 낮은 문제를 개선하는 효과가 있다.

Подробнее
09-07-2020 дата публикации

ADAMANTANECARBOXYLIC ACID BENZYL AMIDE DERIVATIVE COMPOUND AND SKIN WHITENING COMPOSITION COMPRISING SAME

Номер: WO2020141927A1
Принадлежит:

The present specification relates to an adamantanecarboxylic acid benzyl amide derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, and a skin whitening composition comprising same as an active ingredient. Specifically, the compound, according to the present specification, is a compound having a novel structure having adamantanecarboxylic acid bound to an amine compound, and exhibits a skin whitening effect by inhibiting the production of melanin, and thus may be used in various ways as a pharmaceutical composition, a cosmetic composition or a skin preparation for external use.

Подробнее
04-04-2018 дата публикации

PSEUDOCERAMIDE COMPOUND AND PREPARATION METHOD THEREOF

Номер: KR1020180034044A
Принадлежит:

The present invention relates to a pseudoceramide compound and a preparation method thereof. The pseudoceramic compound according to the present invention has a molecular structure and function similar to those of natural ceramides, is easy to synthesize, and has excellent solubility and stability in an organic solvent, and thereby can be utilized as a substitute for the natural ceramides. Accordingly, the pseudoceramide compound of the present invention can be widely applied to skin external preparations and cosmetic compositions for enhancing and maintaining the skin barrier function. COPYRIGHT KIPO 2018 ...

Подробнее
09-03-2016 дата публикации

NOVEL ADAMANTANE DERIVATIVE COMPOUND

Номер: KR1020160026678A
Принадлежит:

The present invention discloses: a novel adamantane derivative compound; an isomer thereof; a pharmaceutically acceptable salt thereof; a prodrug thereof; a hydrate thereof; or a solvate thereof. In addition, disclosed are a method for producing the novel adamantane derivative compound, the isomer thereof, the pharmaceutically acceptable salt thereof, the prodrug thereof, the hydrate thereof, or the solvate thereof. The novel adamantane derivative compound or the like has an excellent androgen inhibitory effect. COPYRIGHT KIPO 2016 ...

Подробнее
23-12-2010 дата публикации

HEALTH FOOD OR PHARMACEUTICAL COMPOSITION COMPRISING CHESTNUT SHELL EXTRACT

Номер: WO2010147440A3
Принадлежит:

The present invention relates to a health food or pharmaceutical composition for alleviating or suppressing pruritus, comprising chestnut shell extract as an active ingredient. In one example of the present invention, the chestnut shell extract comprised in the health food or pharmaceutical composition of the present invention can suitably be used as the active ingredient of a health food or pharmaceutical composition for alleviating or suppressing pruritus as it has been confirmed that it can exhibit an outstanding effect in alleviating or suppressing pruritus by suppressing the activity of proteinase-activated receptor-2 (PAR-2) which is a source of stimulation in pruritus.

Подробнее
29-04-2016 дата публикации

ANTIBACTERIAL COMPOSITION CONTAINING MESO-2,3-BUTANEDIOL

Номер: KR1020160046638A
Принадлежит:

The present invention relates to an antibacterial composition containing meso-2,3-butanediol represented by chemical formula 1, which is an isomer of 2,3-butanediol, thereby being capable of effectively controlling bacteria and exhibiting superior antibacterial effects even in small amounts. COPYRIGHT KIPO 2016 ...

Подробнее
06-10-2016 дата публикации

ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE

Номер: WO2016159640A3
Принадлежит:

... 5-Adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide disclosed in the present specification can exhibit excellent anti-oxidative and anti-aging effects while having no toxicity. For example, the compound exhibits excellent anti-oxidative and anti-aging effects by scavenging free radicals or inhibiting MMP-1 expression.

Подробнее
14-02-2013 дата публикации

NOVEL BENZOIC ACID AMIDE COMPOUND

Номер: WO2013022236A2
Принадлежит:

The present invention relates to a novel benzoic acid amide derivative compound, isomers thereof, pharmaceutically acceptable salts thereof, prodrugs thereof, hydrates thereof, or solvates thereof. The novel compound has excellent skin whitening effects.

Подробнее
07-11-2018 дата публикации

자외선 차단용 유무기 복합분체 및 이를 함유하는 화장료 조성물

Номер: KR0101915973B1
Принадлежит: (주)아모레퍼시픽

... 본 발명은 자외선 차단용 유무기 복합분체 및 이를 함유하는 화장료 조성물에 관한 것으로서, 보다 자세하게는 무기분체의 표면을 인지질로 처리하여 자외선 차단능과 분산성이 향상된 유무기 복합분체 및 상기 복합분체를 함유하여 피부에 도포시 사용감 및 보습력이 개선된 화장료 조성물에 관한 것이다.

Подробнее
02-12-2010 дата публикации

COMPOSITION CONTAINING A BEAN EXTRACT FOR IMPROVING BLOOD CIRCULATION AND INCREASING VASCULAR HEALTH

Номер: WO2010137875A3
Принадлежит:

The present invention relates to a composition containing a bean extract extracted by low-concentration, low-grade alcohol or fractions thereof. The composition exhibits excellent effects in improving blood circulation, improving obesity, and preventing diabetes, hyperlipidemia and the like, and exhibits the effects of alleviating or treating the symptoms of diabetes, hyperlipidemia, and the like.

Подробнее
14-02-2013 дата публикации

NOVEL BENZOIC ACID AMIDE COMPOUND

Номер: WO2013022236A3
Принадлежит:

The present invention relates to a novel benzoic acid amide derivative compound, isomers thereof, pharmaceutically acceptable salts thereof, prodrugs thereof, hydrates thereof, or solvates thereof. The novel compound has excellent skin whitening effects.

Подробнее
04-07-2017 дата публикации

PSEUDOCERAMIDE COMPOUND AND PRODUCTION METHOD THEREOF

Номер: KR1020170076561A
Принадлежит:

The present invention relates to a pseudoceramide compound, and a production method thereof. The pseudoceramide compound provides antioxidative effects, and can be contained in formulation in a large amount owing to high solubility and enhanced physical properties, compared to existing natural ceramide and pseudoceramide compounds. Accordingly, the pseudoceramide compound can be widely applied to cosmetic products, drugs, agents for external application, and foods. COPYRIGHT KIPO 2017 ...

Подробнее
10-10-2016 дата публикации

COMPOSITION FOR ANTI-OXIDATION OR ANTI-AGING COMPRISING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE

Номер: KR1020160116941A
Принадлежит:

According to the present invention, 5-adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide exhibits excellent anti-oxidant and anti-aging effects without having toxicity. For example, the 5-adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide exhibits excellent anti-oxidant and anti-aging effects by eliminating free radicals, or suppressing expression of MMP-1. COPYRIGHT KIPO 2016 ...

Подробнее
07-11-2016 дата публикации

COMPOSITION COMPRISING COLORED BEAN EXTRACT

Номер: KR1020160128277A
Принадлежит:

The present invention relates to a composition having antithrombotic effects, comprising a fraction of a colored bean extract extracted from a colored bean or the like as an active ingredient. According to the present invention, the antithrombotic composition comprising adenosine can be efficiently used for treating circulatory disease such as cardiovascular diseases, cerebrovascular diseases, arteriosclerosis, high blood pressures, diabetes mellitus, and the like, which can be the cause of thrombus formation. COPYRIGHT KIPO 2016 (AA) Platelet aggregation inhibition (%) (BB) Time (Minute) ...

Подробнее
08-03-2012 дата публикации

NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR

Номер: KR2012030170A2
Принадлежит:

Disclosed are a novel compound acting as a cannabinoid receptor-1 inhibitor, a prodrug thereof, a pharmaceutically acceptable salt thereof, and a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by cannabinoid receptor-1.

Подробнее
20-05-2010 дата публикации

NOVEL COMPOUND ACTING AS A VANILLOID RECEPTOR ANTAGONIST, ISOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Номер: KR2010056044A2
Принадлежит:

The present invention relates to a novel compound acting as a vanilloid receptor (VR1; TRPV1) antagonist, to an isomer or pharmaceutically acceptable salt thereof, and to a pharmaceutical composition containing same. The present invention provides a pharmaceutical composition for preventing or treating diseases such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, respiratory disorder, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease, etc. The present invention also provides a composition for preventing skin aging, or to a composition for alleviating skin irritation.

Подробнее
22-12-2011 дата публикации

COMPOSITION CONTAINING COLORED-BEAN EXTRACTS

Номер: WO2011159134A3
Принадлежит:

The present invention relates to an antithrombotic composition which contains, as active ingredients, fractions of colored-bean extracts obtained from colored beans or the like. The antithrombotic composition of the present invention can be significantly effectively used in the treatment of cardiovascular diseases, cerebrovascular diseases, and circulatory diseases such as atherosclerosis, hypertension, diabetes, and the like, wherein the diseases are caused by the formation of thrombi.

Подробнее
22-12-2011 дата публикации

COMPOSITION CONTAINING COLORED BEAN EXTRACT

Номер: KR2011159133A2
Принадлежит:

The present invention relates to an antithrombogenic composition containing a colored bean extract extracted from colored beans and the like and a fraction thereof as active ingredients. The antithrombogenic composition according to the present invention can be very useful to treating diseases of the circulatory system such as cardiovascular diseases, cerebral vascular diseases, arteriosclerosis, hypertension, diabetes and the like caused by thrombus formation.

Подробнее
10-10-2016 дата публикации

ANTI-INFLAMMATORY COMPOSITION COMPRISING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE

Номер: KR1020160116958A
Принадлежит:

According to the present invention, 5-adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide can exhibit an excellent anti-inflammatory effect without having cytotoxicity. For example, the 5-adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide suppresses the generation of at least one from NO and PGE2, the activity of at least one from NF-κB and AP-1 which are transcription factors, or the inflammatory cytokine such as IL-1β, thereby exhibiting an excellent anti-inflammatory effect. COPYRIGHT KIPO 2016 ...

Подробнее
16-05-2013 дата публикации

COMPOSITION COMPRISING CARNOSIC ACID OR DERIVATIVE THEREOF

Номер: WO2013070018A1
Принадлежит:

The present invention relates to a skin irritation alleviation agent comprising carnosic acid, a derivative thereof or a pharmaceutically acceptable salt thereof. The present invention relates to a C-kit activity inhibitor comprising carnosic acid, a derivative thereof or a pharmaceutically acceptable salt thereof. The present invention relates to an elastase activity inhibitor or matrix metalloproteinase (MPP) expression inhibitor comprising carnosic acid, a derivative thereof or a pharmaceutically acceptable salt thereof. The present invention also relates to a whitening composition or anti-ageing composition comprising a carnosic acid derivative or a pharmaceutically acceptable salt thereof.

Подробнее
12-07-2018 дата публикации

SOLUBILIZING AGENT FOR TRANSPARENT OR TRANSLUCENT OIL-IN-WATER FORMULATION AND COSMETIC COMPOSITION COMPRISING SAME

Номер: WO2018128465A1
Принадлежит:

The present specification relates to a solubilizing agent for a transparent or translucent oil-in-water formulation and a cosmetic composition comprising the same, wherein the solubilizing agent is used in a transparent or translucent oil-in-water formulation comprising a fat-soluble physiologically active substance, and comprises a polysorbate 20-cinnamic acid conjugate in which polysorbate 20 is bonded to a cinnamic acid. The solubilizing agent and a composition comprising the same have excellent water dispersion stability with respect to a water phase of the fat-soluble physiologically active substance.

Подробнее
21-12-2018 дата публикации

유색콩 추출물을 함유하는 조성물

Номер: KR0101932246B1
Принадлежит: (주)아모레퍼시픽

... 본 발명은 유색콩 등으로부터 추출한 유색콩 추출물 및 그 분획물을 유효성분으로 함유하는 항혈전 효능 조성물에 관한 것이다. 본 발명에 의한 항혈전 조성물은 아데노신을 포함하고 있으며, 혈전 형성의 원인이 되는 심장혈관질환, 뇌혈관질환, 동맥경화증, 고혈압, 당뇨 등의 순환기계 질환의 치료에 매우 유용하게 이용될 수 있다.

Подробнее
28-04-2016 дата публикации

COMPOSITION CONTAINING MESO-2,3-BUTANEDIOL

Номер: WO2016064180A1
Принадлежит:

The present invention relates to a composition which can effectively control bacteria by containing meso-2,3-butanediol, which is an isomer of 2,3-butane diol, and has excellent antiseptic power even without containing a chemical preservative.

Подробнее
01-02-2017 дата публикации

COMPOSITION FOR PROMOTING VASCULAR HEALTH AND IMPROVING BLOOD CIRCULATION, CONTAINING SOYBEAN EXTRACT

Номер: KR1020170010885A
Принадлежит:

The present invention relates to a composition containing a soybean extract extracted using low concentration low quality alcohol, or a fraction thereof. The composition of the present invention is excellent in improving blood circulation as well as obesity, and is also effective in preventing or treating diabetes and hyperlipidemia, or relieving symptoms thereof. COPYRIGHT KIPO 2017 (210) Image input unit (220) Storage unit (230) Tolerance correcting unit (240) Image synthesis unit (250) Display unit ...

Подробнее
13-02-2024 дата публикации

다이아릴 유도체 화합물 및 그를 포함하는 피부 미백용 조성물

Номер: KR102635194B1
Принадлежит: (주)아모레퍼시픽

... 다이아릴 유도체 화합물, 이의 이성질체, 이의 약학적으로 허용 가능한 염, 이의 수화물 또는 이의 용매화물, 및 이를 유효 성분으로 포함하는 피부 미백용 조성물에 관한 것이다. 구체적으로 본 명세서에 따른 화합물은 폴리페놀기와 아다만틸 페닐이 연결되어 있는 신규한 구조의 화합물로서, 멜라닌 생성을 억제시켜 미백 효과를 가지므로, 약학 조성물, 화장료 조성물 또는 피부 외용제 등으로 다양하게 활용될 수 있다. 또한, 종래 미백 물질과 비교하여 수급이 용이한 출발물질을 이용하여 제조되므로, 대량 생산이 가능하다.

Подробнее
29-06-2017 дата публикации

PSEUDO-CERAMIDE COMPOUND AND PREPARATION METHOD THEREFOR

Номер: WO2017111387A1
Принадлежит:

The present invention relates to a pseudo-ceramide compound and a preparation method therefor. The pseudo-ceramide compound of the present invention can provide an antioxidative effect, and can exhibit improved physical properties, such as high solubility, compared with existing natural ceramide and pseudo-ceramide compounds, and thus can be contained in a large amount in a formulation. Therefore, the pseudo-ceramide compound can be applied in various fields to cosmetics, medicinal materials, agents for external application, foods, and the like.

Подробнее
05-01-2017 дата публикации

METHOD FOR PREPARING BENZOIC ACID AMIDE COMPOUND

Номер: WO2017003107A1
Принадлежит:

The present invention relates to a method for preparing a benzoic acid amide compound in a high yield by presenting a novel method for preparing a benzyl amine compound to be used as a reactant and delimiting the reaction condition of each step by using the same, and the method is economically advantageous since mass production is possible.

Подробнее
08-06-2015 дата публикации

IONONE DERIVATIVE COMPOUND

Номер: KR1020150062443A
Принадлежит:

An aspect of the present invention relates to an ionone derivative compound, an isomer of the same, a pharmaceutically allowable salt of the same, a prodrug of the same, a hydrate of the same, or a solvate of the same. Another aspect of the present invention relates to a composition for preventing skin-aging, wherein an ionone derivative compound, an isomer of the same, a pharmaceutically allowable salt of the same, a prodrug of the same, a hydrate of the same, or a solvate of the same is included. COPYRIGHT KIPO 2015 ...

Подробнее